Development of large platelet aggregates from small aggregates as determined by laser-light scattering: Effects of aggregant concentration and antiplatelet medication

Thrombosis and Haemostasis

Volumn 75, Issue 5, 1996, Pages 838-843

  Tohgi, Hideo ^a   Takahashi, Hiroaki ^a   Watanabe, Katsumi ^a   Kuki, Hiroyuki ^a   Shirasawa, Yoshiaki ^b  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b KOWA COMPANY LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; COLLAGEN; TICLOPIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LASER; LIGHT SCATTERING; MAJOR CLINICAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0030008421     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650376     Document Type: Article

References (22)

1. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
2. Born GVR. Observations on the change in shape of blood platelets brought about by adenosine diphoshate. J Physiol 1970; 209: 487-511.
3. Born GVR, Hume M. Effects of the numbers and sizes of platelet aggregates on the optical density of plasma. Nature 1967; 215: 1027-9.
4. Cardinal DL, Flower RJ. The electronic aggregometer: A novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3: 135-58.
5. Ries H, Braun G, Brehm G, Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol. 1986; 85: 50-6,
6. Ingerman-Wojenski C, Smith JB, Silver MJ. Evaluation of electrical aggregometry: platelets. J Lab Clin Med. 1983; 101: 44-52.
7. Nichols AR, Bosmann HB. Platelet aggregation: Newly quantified using nonempirical parameters. Thromb Haemost 1979; 42: 679-93.
8. Kitek A, Breddin K. Optical density variations and microscopic observations in the evaluation of platelet shape change and microaggregate formation. Thromb Haemost 1980; 44: 154-8.
9. Gear RL, Lambrecht JK. Reduction in single platelets during primary and secondary aggregation. Thromb Haemost 1981; 45: 298.
10. Latimer P, Born GVR, Michal F. Application of light-scattering theory to the optical effects associated with the morphology of blood platelets. Arch Biochem Biophys 1977; 180: 151-9.
11. Born GVR, Dearnley R, Foulks JG, Sharp DE. Quantification of the morphological reaction of platelets to aggregating agents and its reversal by aggregation inhibitors. J Physiol 1978; 280: 193-212.
12. Latimer P. Blood platelet aggregometry: The proposed use of scattered instead of transmitted light. Biophys J 1984; 45: 21a.
13. Hantgan RR. A study of kinetics and mechanism of ADP-triggered platelet aggregation. Biochim Biophys Acta 1985; 846: 64-75.
14. Hubbell JA, Pohl PI, Wagner WR. The use of laser-light scattering and controlled shear in platelet aggregometry. Thromb Haemost 1991; 65: 601-7.
15. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218: 284-94.
16. Karniguian A, Grelac F, Levy-Toledano S, Legrand YJ, Rendu F, Collagen-induced platelet activation mainly involves the protein kinase C pathway. Biochem J 1990; 268: 325-31.
17. Nakano T, Hanasaki K, Arita H. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets. J Biol Chem 1989; 264: 5400-6.
18. Saltiel E, Ward A. Ticlopidine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Drugs 1987; 34: 222-62.
19. Ashida S-I, Abiko Y. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat. Thromb Haemost 1979; 41: 436-49.
20. Di Minno G, Cerbone AM, Mattioli PL, Turco S, Iovine C, Mancini M. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 1985; 75: 328-38.
21. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Brit J Med 1994; 308: 81-106.
22. Uchiyama S, Sone R, Nagayama T, Shibagaki Y, Kobayashi I, Maruyama S, Kusakabe K. Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia. Stroke 1989; 20: 1643-7.